Category: Jurisdictions
-
Federal Circuit partly grants Bayer second chance in defending rivaroxaban patent invalidation campaign
The Federal Circuit has partly affirmed and partly vacated a United States Patent and Trademark Office’s Patent Trial and Appeal Board decision that deemed one of Bayer’s rivaroxaban-related patents invalid, in a three-year case initiated by rivals Mylan Pharmaceuticals, Teva Pharmaceuticals, and Invagen Pharmaceuticals.
-
Delhi HC denies Nokia’s request to impose more restrictions on use of confidential SEP license information than UPC Munich
This article is available for free because the related enforcement campaign involves video streaming patents. It is a protective order that resolves a few disputed questions of FRAND disclosure.
-
Headwater launches fresh cloud messaging patent infringement campaign: Tencent, Uber, Target, Walmart among defendants
The patent infringement campaign appears to be targeting Google customers, as the complaints all refer to the company’s Firebase Cloud Messaging, and it asserts a patent also involved in a recently-settled dispute with Samsung Electronics.
-
American Express handed win in loyalty program patent infringement dispute
A U.S. district court has granted a motion to dismiss a complaint filed by Loyal-T Systems LLC against American Express for failing to state a claim for relief.
-
Moderna, Alnylam settle U.S. COVID vaccine patent infringement dispute
Alnylam has settled its three-year dispute against Moderna in the District of Delaware, after a precedential Federal Circuit decision found the patentee had acted as its own lexicographer in defining a key patent specification term, foreclosing its infringement allegations.
-
Doctrine of equivalents removes painkiller from German market: Grünenthal wins preliminary injunction on appeal
A pharma patent and unfair competition dispute has taken a remarkable turn as the Dusseldorf Higher Regional Court granted a preliminary injunction based on infringement by equivalents.
-
Samsung, Headwater settle wireless patent dispute
Samsung and Headwater Research have settled a two-year patent infringement dispute.
-
Regeneron makes strides in global Eylea patent enforcement campaign: settles with Sandoz, files fresh UK suits
Regeneron has settled its year-long patent infringement dispute with Sandoz over several patents related to its eye disease drug Eylea, and filed a fresh lawsuit against two more rivals over the same drug in the High Court of Justice for England & Wales.
-
Pharma and Biotech Patent Litigation Summit Europe returns in 2026: rebranded event features tech industry track, UPC litigation forum
Kisaco Research’s annual Pharma and Biotech Patent Litigation Summit Europe will take place from January 19 to January 21 in the Beurs van Berlage, Amsterdam, with ip fray as an official media partner.
-
InterDigital’s Brazilian double whammy against Disney: preliminary (but merits-based) injunction over two streaming patents
InterDigital’s merits-based two-patent injunction is harder to get stayed or overturned than most Brazilian patent PIs.